MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


PureTech Health's Gelesis hires Jane Wildman to board ahead of US product launch

StockMarketWire.com

Clinical-stage biotherapeutics company PureTech Health's founded entity Gelesis has appointed Procter & Gamble veteran Jane Wildman to its board of directors.

Marketing executive Wildman, who spent more than 25 years at Procter & Gamble, has joined Gelesis as the company prepares for the US launch of its commercial product Plenity this year.

Chief executive and founder of Gelesis Yishai Zohar said: 'We believe we can help fundamentally change how the world addresses weight management. Jane has devoted her career to building brands that solve consumer problems, and her marketing and branding expertise will help us as we launch Plenity later this year.'

Wildman added: 'With Plenity, we have the unique opportunity to change the stigmatised conversation around weight.'

At 1:13pm: (LON:PRTC) Puretech Health PLC share price was 0p at 282p



Story provided by StockMarketWire.com